Steven B. Leichter

Clinical and Metabolic Aspects of Glucagonoma

Steven B. Leichter · Medicine · 1980 · 98 citations

Metabolic Disorder, Gastroenterology, Pathology +17

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith et al. · The Lancet Diabetes & Endocrinology · 2023 · 98 citations · Full text

Metabolic Syndrome, Diabetes Management, Young People +11

Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma

Steven B. Leichter, Anthony S. Pagliara, Marie H. Greider et al. · The American Journal of Medicine · 1975 · 75 citations

Insulin Management, Diabetes, Islet Cell Carcinoma +4

Readability of Self-Care Instructional Pamphlets for Diabetic Patients

Steven B. Leichter, Janice A Nieman, Robert W. Moore et al. · Diabetes Care · 1981 · 50 citations

Education, Self-care Intervention, Program Evaluation +20

Combination Medications in Diabetes Care: An Opportunity That Merits More Attention

Steven B. Leichter, Stephanie Thomas · Clinical Diabetes · 2003 · 39 citations · Full text

Pharmacotherapy, More Attention, Molecular Pharmacology +18